{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:06:55Z","timestamp":1781575615674,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS KAKENHI","award":["20K07031"],"award-info":[{"award-number":["20K07031"]}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kobayashi Foundation"},{"DOI":"10.13039\/501100012036","name":"LOTTE Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bbalip.2020.158858","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:36:07Z","timestamp":1607024167000},"page":"158858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease"],"prefix":"10.1016","volume":"1866","author":[{"given":"Ami","family":"Oguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferbian Milas","family":"Siswanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Imaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Imaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2020.158858_bb0005","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.jalz.2007.10.005","article-title":"Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses","volume":"4","author":"Cansev","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbalip.2020.158858_bb0010","series-title":"Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials, Int J Mol Sci, 20","author":"Avallone","year":"2019"},{"key":"10.1016\/j.bbalip.2020.158858_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2013.09.023","article-title":"Dietary fat intake, pesticide use, and Parkinson\u2019s disease","volume":"20","author":"Kamel","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbalip.2020.158858_bb0020","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2020.158858_bb0025","doi-asserted-by":"crossref","first-page":"a008862","DOI":"10.1101\/cshperspect.a008862","article-title":"The history of Parkinson's disease: early clinical descriptions and neurological therapies","volume":"1","author":"Goetz","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bbalip.2020.158858_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2007.10.019","article-title":"Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies","volume":"77","author":"Calon","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bbalip.2020.158858_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biochi.2020.01.013","article-title":"Brain targeting with docosahexaenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier","volume":"170","author":"Hachem","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.bbalip.2020.158858_bb0040","doi-asserted-by":"crossref","first-page":"14784","DOI":"10.1096\/fj.201901872R","article-title":"Expression of Cyp2c\/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice","volume":"33","author":"Graves","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2020.158858_bb0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1212\/WNL.0b013e3181b2851b","article-title":"Neurodegeneration associated with genetic defects in phospholipase A2","volume":"73","author":"Sadeh","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2020.158858_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2008.01.002","article-title":"Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450","volume":"471","author":"Fer","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2020.158858_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/092986712798918851","article-title":"n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation","volume":"19","author":"Farooqui","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbalip.2020.158858_bb0060","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158858_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.54","article-title":"CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity Through SIRT1","volume":"1","author":"Samokhvalov","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bbalip.2020.158858_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","article-title":"An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension","volume":"64","author":"Ulu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbalip.2020.158858_bb0075","doi-asserted-by":"crossref","first-page":"E5815","DOI":"10.1073\/pnas.1802179115","article-title":"Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease","volume":"115","author":"Ren","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2020.158858_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12035-014-8833-3","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates MPTP-induced parkinsonism","volume":"52","author":"Qin","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbalip.2020.158858_bb0085","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1172\/JCI123835","article-title":"Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity","volume":"129","author":"Hu","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2020.158858_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20131494","article-title":"Muller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid","volume":"211","author":"Hu","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2020.158858_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbalip.2020.158858_bb0100","doi-asserted-by":"crossref","first-page":"18393","DOI":"10.1074\/jbc.M112.438762","article-title":"Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2)","volume":"288","author":"Baba","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158858_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2133\/dmpk.24.438","article-title":"Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression","volume":"24","author":"Oguro","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bbalip.2020.158858_bb0110","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1038\/s41598-017-06630-0","article-title":"Potentiation of 17beta-estradiol synthesis in the brain and elongation of seizure latency through dietary supplementation with docosahexaenoic acid","volume":"7","author":"Ishihara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158858_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.prostaglandins.2015.06.005","article-title":"Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): resulting drug levels and modulation of oxylipin pattern","volume":"121","author":"Ostermann","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.bbalip.2020.158858_bb0120","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2133\/dmpk.20.478","article-title":"Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs","volume":"20","author":"Imaoka","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bbalip.2020.158858_bb0125","first-page":"731","article-title":"Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450","volume":"18","author":"Imaoka","year":"1989","journal-title":"Biochem. Int."},{"key":"10.1016\/j.bbalip.2020.158858_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.428","article-title":"14,15-epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells","volume":"6","author":"Oguro","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbalip.2020.158858_bb0135","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1194\/jlr.M800199-JLR200","article-title":"Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism","volume":"49","author":"Fer","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158858_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.03.069","article-title":"Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats","volume":"611","author":"Ishihara","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2020.158858_bb0145","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1038\/s41598-017-02914-7","article-title":"Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that regulate neurotransmission","volume":"7","author":"Hennebelle","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158858_bb0150","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158858_bb0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20305","article-title":"Variable effects of chronic subcutaneous administration of rotenone on striatal histology","volume":"478","author":"Zhu","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbalip.2020.158858_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0306-4522(97)00649-0","article-title":"Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase","volume":"86","author":"Watts","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbalip.2020.158858_bb0165","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1289\/ehp.10828","article-title":"Developmental exposure to polychlorinated biphenyls influences stroke outcome in adult rats","volume":"116","author":"Dziennis","year":"2008","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbalip.2020.158858_bb0170","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","article-title":"Soluble epoxide hydrolase: a novel therapeutic target in stroke","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbalip.2020.158858_bb0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","article-title":"Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism","volume":"163","author":"Marowsky","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbalip.2020.158858_bb0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.114.061242","article-title":"Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain","volume":"43","author":"Booth Depaz","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbalip.2020.158858_bb0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1369\/jhc.2008.950659","article-title":"Distribution and expression of soluble epoxide hydrolase in human brain","volume":"56","author":"Sura","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbalip.2020.158858_bb0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1194\/jlr.M031914","article-title":"Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo","volume":"54","author":"Kundu","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158858_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2016.10.012","article-title":"The protective mechanism of docosahexaenoic acid in mouse model of Parkinson: the role of hemeoxygenase","author":"Ozkan","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbalip.2020.158858_bb0200","doi-asserted-by":"crossref","first-page":"107976","DOI":"10.1016\/j.neuropharm.2020.107976","article-title":"Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum","volume":"167","author":"Chitre","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbalip.2020.158858_bb0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2018.10.001","article-title":"Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson\u2019s disease: the role of glia and NRf2 regulation","volume":"121","author":"Hernando","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2020.158858_bb0210","doi-asserted-by":"crossref","first-page":"101686","DOI":"10.1016\/j.jchemneu.2019.101686","article-title":"Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice","volume":"102","author":"El Fari","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bbalip.2020.158858_bb0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuint.2018.10.015","article-title":"Docosahexaenoic acid protection in a rotenone induced Parkinson\u2019s model: prevention of tubulin and synaptophysin loss, but no association with mitochondrial function","volume":"121","author":"Serrano-Garcia","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbalip.2020.158858_bb0220","first-page":"716","article-title":"Four main therapeutic keys for Parkinson\u2019s disease: a mini review","volume":"22","author":"Hernandez-Baltazar","year":"2019","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.bbalip.2020.158858_bb0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/nu8020099","article-title":"Docosahexaenoic acid and cognition throughout the lifespan","volume":"8","author":"Weiser","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2020.158858_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/09637486.2017.1413640","article-title":"The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice","volume":"69","author":"Valentini","year":"2018","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.bbalip.2020.158858_bb0235","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1096\/fj.201600360R","article-title":"Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid","volume":"30","author":"Markworth","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2020.158858_bb0240","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1194\/jlr.M034918","article-title":"Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets","volume":"54","author":"Bruins","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158858_bb0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12974-019-1508-2","article-title":"Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity","volume":"16","author":"Hung","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbalip.2020.158858_bb0250","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1073\/pnas.1705615114","article-title":"Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3beta signaling","volume":"114","author":"Deng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819812030250X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819812030250X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:08:43Z","timestamp":1761386923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138819812030250X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S138819812030250X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2020.158858","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2020.158858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"158858"}}